Protecting renal function in diabetes through modern evidence-based medical protocols (SGLT2i, Finerenone, GLP-1 RA, and BP control).
Diabetic Kidney Disease (DKD), also known as diabetic nephropathy, is the leading cause of chronic kidney disease and end-stage renal failure worldwide. Up to 40% of individuals with long-standing Type 1 or Type 2 diabetes develop kidney damage due to microvascular capillary injury caused by persistent high blood sugar.
At Swasth Kidney Clinic, Dr. Vishal Singh emphasizes early detection through annual microalbuminuria screening and proactive renal-protective treatment. By integrating modern breakthroughs — such as SGLT2 inhibitors (Empagliflozin/Dapagliflozin), non-steroidal MRAs (Finerenone), GLP-1 receptor agonists, and RAAS inhibitors — we effectively halt or significantly slow kidney decline in diabetic patients.
A structured, compassionate approach from initial consultation through diagnosis, specialized therapy, and long-term surveillance.
Personalized diagnostic and treatment pathways addressing specific stages and variations of kidney disease.
With 31+ years of nephrology practice, military leadership, and academic fellowships, Dr. Vishal Singh delivers world-class, compassionate kidney care.
Get clear, medically verified answers about diagnosis, treatment options, and disease progression.
Consult Dr. Vishal Singh at Swasth Kidney Clinic, Greater Noida or Max Hospital, Vaishali.